Australia markets open in 9 hours 54 minutes

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7950-0.0050 (-0.18%)
As of 10:05AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.1-0.1-0.39-0.39
Low estimate-0.11-0.1-0.41-0.43
High estimate-0.08-0.09-0.36-0.35
Year ago EPS-0.1-0.12-0.44-0.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate1.76M1.69M6.6M5.9M
Low estimate1.1M1.1M4.6M3.7M
High estimate3.1M2.7M9.8M7.79M
Year ago sales4.65M4.66M18.14M6.6M
Sales growth (year/est)-62.20%-63.70%-63.60%-10.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.11-0.11-0.12-0.11
Actual EPS-0.1-0.12-0.12-0.1
Difference0.01-0.0100.01
Surprise %9.10%-9.10%0.00%9.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.1-0.1-0.39-0.39
7 days ago-0.11-0.12-0.45-0.53
30 days ago-0.11-0.12-0.45-0.53
60 days ago-0.11-0.12-0.45-0.53
90 days ago-0.1-0.11-0.43-0.38
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2342
Up last 30 days2343
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABUSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.16.70%N/AN/AN/A
Current year11.40%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A